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Abstract
Introduction: Pain in scleritis may be difficult to control with conventional immuno-suppressive
regimes. Amitriptyline may be an effective option in those circumstances.
Case presentation: A 41-year-old woman presented with scleritis and eye pain that was refractory
to treatment with steroid and immunosuppressive agents. Effective pain relief and reduction of
steroid dose was only achieved after starting amitriptyline.
Conclusion: Amitriptyline may be an effective option for pain control in case with scleritis which
might otherwise require unnecessarily large doses of immunosuppression.
Introduction
Scleritis may cause pain that is refractory to conventional
treatment with corticosteroids and immunosuppressive
agents. Amitriptyline, a tricyclic anti-depressant some-
times used for neuropathic pain [1], may be an effective
option for pain control in those cases of scleritis.
Case presentation
A 41-year-old Caucasian woman was referred to eye
casualty with a three-day history of a painful, red left
eye. She had had similar episodes of bilateral anterior
scleritis four years ago controlled by intravenous steroids
and oral cyclosporin but had been off all immuno-
suppression therapy for over three years. She was treated
with oral flurbiprofen 100 mg t.d.s. This had no effect and
after 48 hours she was commenced on 80 mg oral
prednisolone. Two days later visual acuity reduced to
6/36 and she was placed on intravenous methylpredniso-
lone 500 mg o.d. for three days. Haematological
investigations excluded any systemic involvement. Ultra-
sound scan confirmed scleritis and MRI scan revealed no
inflammatory orbital masses.
The inflammation and pain gradually settled and visual
acuity improved to 6/6. She was discharged on oral
prednisolone 80 mg daily as a reducing course. At 60 mg
daily, she relapsed and required intravenous methylpre-
dnisolone 1 g stat followed by 500 mg o.d. for one week to
control her inflammation. She declined cyclophos-
phamide because of the risk of side effects. Mycophenolate
was started at 500 mg o.d., slowly increasing to 1 g b.i.d.
She developed weight gain and steroid-induced diabetes.
She was an irregular attender at clinic and despite efforts to
Page 1 of 2
(page number not for citation purposes)wean her off steroids she kept increasing the dose in order
to control her ocular pain using between 60 and 70 mg
prednisolone per day. There was a clear mismatch between
the amount of ocular inflammation clinically and her
symptoms of pain. Five months after presentation a trial of
oral amitriptyline was commenced at 10 mg nocte
increasing to 50 mg nocte over 1 week. This very rapidly
controlled the pain and she was able to reduce her steroid
dose from 60 mg to 15 mg prednisolone daily within
fifteen weeks of starting amitriptyline. At this point her
pain returned but this time with clear clinical evidence of
her scleritis becoming more active. This flare up was
controlled by briefly increasing her prednisolone to 40 mg
daily and her mycophenolate to 1.5 mg b.i.d. She is now
on 10 mg prednisolone o.d., mycophenolate 1.5 mg b.i.d.
and amitriptyline 50 mg nocte without further relapse.
Discussion
Pain in scleritis may be very severe and can often wake the
patient from sleep. Treatment of the inflammation is
usually adequate to control the pain. In this case there was
a clear mismatch between the visible signs of inflamma-
tion and the pain reported by the patient. We believe that
it is important to recognise and distinguish between
treating inflammation and treating pain in such cases to
avoid excessive and unnecessary use of immunosuppres-
sive drugs. A trial of amitriptyline, a tricyclic antidepres-
sant, may be beneficial although it would also be perfectly
reasonable to use other drugs such as gabapentin [2-4].
Conclusion
We can find no report in the literature of amitriptyline
used in this way for patients with scleritis and would
recommend considering its use for the control of pain
from scleritis where the pain is out of proportion to the
inflammation.
Abbreviation
MRI, magnetic resonance imaging.
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